Abstract 17021: A Novel Human Relaxin Receptor Agonist, ML290, Attenuates Atherosclerosis- and Chronic Kidney Disease-Induced Vascular Calcification in Mice Article

Ng, Hooi Hooi, Medina, Daniela, Agoulnik, Alexander I et al. (2020). Abstract 17021: A Novel Human Relaxin Receptor Agonist, ML290, Attenuates Atherosclerosis- and Chronic Kidney Disease-Induced Vascular Calcification in Mice . CIRCULATION, 142(Suppl_3), 10.1161/circ.142.suppl_3.17021

cited authors

  • Ng, Hooi Hooi; Medina, Daniela; Agoulnik, Alexander I; Hutcheson, Joshua

authors

publication date

  • November 17, 2020

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 5 Development of treatments and therapeutic interventions
  • 5.1 Pharmaceuticals
  • Atherosclerosis
  • Cardiovascular
  • Heart Disease
  • Heart Disease - Coronary Heart Disease
  • Kidney Disease
  • Nutrition
  • Prevention

Digital Object Identifier (DOI)

publisher

  • Wolters Kluwer

volume

  • 142

issue

  • Suppl_3